Drug Development Archives

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

Blog

FAQs on Developing EMA Policy 0070 Submissions

This blog answers audience questions posed during our RAPS webinar, How to Plan for a…

CertaraSeptember 15, 2025

Guide

The Top 10 Things You Need to Know About ADNCA Datasets

Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…

CertaraSeptember 11, 2025

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle PillsburySeptember 10, 2025

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

CertaraSeptember 9, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

CertaraSeptember 5, 2025

Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Learn how Certara's project management team helped a large biotech streamline the development and updates…

CertaraSeptember 5, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

CertaraSeptember 4, 2025

Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

CertaraSeptember 3, 2025

Drug Development